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Abstract
The L-toxin gene isolated from Clostridium perfringens type B was expressed as a glutathione S-transferase (GST) fusion
gene in Escherichia coli. The purified GST-L-toxin fusion protein from the E. coli transformant cells was not lethal. The
N-terminal amino acid sequence of the recombinant L-toxin (r toxin) isolated by thrombin cleavage of the fusion protein was
G-S-N-D-I-G-K-T-T-T. Biological activities and molecular mass of r toxin were indistinguishable from those of native
L-toxin (n toxin) purified from C. perfringens type C. Replacement of Cys-265 with alanine or serine by site-directed
mutagenesis resulted in little loss of the activity. Treatment of C265A with N-ethylmaleimide (NEM), which inactivated
lethal activity of r toxin and n toxin, led to no loss of the activity. The substitution of tyrosine or histidine for Cys-265
significantly diminished lethal activity. In addition, treatment of C265H with ethoxyformic anhydride which specifically
modifies histidyl residue resulted in significant decrease in lethal activity, but that of r toxin with the agent did not. These
results showed that replacement of the cysteine residue at position 265 with amino acids with large size of side chain or
introduction of functional groups in the position resulted in loss of lethal activity of the toxin. Replacement of Tyr-266, Leu-
268 or Trp-275 resulted in complete loss of lethal activity. Simultaneous administration of r toxin and W275A led to a
decrease in lethal activity of L-toxin. These observations suggest that the site essential for the activity is close to the cysteine
residue. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Clostridium perfringens L-toxin is thought to be the
signi¢cant agent in the causation of necrotic enteritis
caused by the type C strains, which is characterized
by hemorrhagic mucosal ulceration or super¢cial
mucosal necrosis of the small intestine [1^3]. We
have reported the extensive puri¢cation of L-toxin
produced by C. perfringens type C and some of the
physicochemical properties of the toxin [4^6]. We
reported the toxin acts on the autonomic nervous
system and produces arterial constriction [7,8]. We
also reported that the toxin is inhibited by sulfhydryl
group reagents and oxidizing agents, the toxin
treated with p-chlormercuribenzoate (PCMB) and
oxidizing agents is reactivated by reduced glutathione
and reductants, respectively, and that the number of
thiol group is one per mol of L-toxin from C. per-
fringens [9,10]. The L-toxin gene from C. perfringens
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has been cloned and sequenced [11]. The deduced
amino acid sequence showed that the toxin contains
only one cysteine residue. These observations have
led to the belief that the sulfhydryl group plays a
critical role in the toxin activity. However, the pre-
cise role of the cysteine residue plays in toxin activity
is unclear.
Expression of the cloned L-toxin gene in Escheri-
chia coli resulted in production of high molecular
mass protein [11]. The L-toxin showed a polymeric
form, which is inactive. Furthermore, Steinthorsdot-
tir et al. [12] reported that treatment of the GST-L-
toxin fusion protein from the gene constructed using
pGEX-3X vector with Factor Xa caused no activity
of the toxin. Therefore, we tried to construct the
GST-L-toxin gene using pGEX-4T-1 vector and iso-
late the active form of r toxin from GST-L-toxin
fusion protein. Furthermore, we replaced the single
cysteine residue and amino acid residues near the
cysteine residue with other amino acids by site-di-
rected mutagenesis, and examined lethal activity of
variant L-toxins constructed.
2. Materials and methods
2.1. Puri¢cation of L-toxin from C. perfringens type C
Procedures for culture of C. perfringens type C
(CN5386) and puri¢cation of L-toxin were described
previously [4,6].
2.2. Bacterial strains and plasmid
C. perfringens type B (NCTC 8533) and E. coli
JM109 were used as bacterial strains. pT7-Blue vec-
tor (Novagen) was used for cloning and pGEX-4T-1
(Pharmacia) was used for cloning and expression of
the L-toxin gene.
2.3. Preparation of DNA
C. perfringens was anaerobically cultured at 37‡C
in brain heart infusion broth. Chromosomal DNA
was isolated from the bacteria used in this study
according to the method described previously [11].
DNA extracted from C. perfringens was puri¢ed by
centrifugation through a gradient of cesium chloride
[13]. Large- and small-scale plasmid isolation were
performed as described by Sambrook et al. [13].
2.4. PCR ampli¢cation and cloning
C. perfringens DNA encoding the L-toxin gene was
ampli¢ed by using the polymerase chain reaction
(PCR) with a set of primers L-1 (5P-TTTAACTTAA-
CAGATCATCTATA-3P) and L-2 (5P-ACTAATTT-
GAAATTCATATTAGT-3P), selected on the basis of
nucleotide sequence described [11]. The PCR was
performed for 25 cycles at 94‡C for 1 min, 45‡C
for 30 s and 72‡C for 2 min. The PCR products
were gel-puri¢ed, and ligated into pT7-Blue vector
(plasmid pTB-1). Plasmid pTB-1 was used as a tem-
plate for PCR to add a BamHI site for subcloning
into the vector using a primer 5P-GGGGATCCAAT-
GATATAGGTAAAC-3P (BamHI site is underlined)
and a reverse primer. The product was isolated, di-
gested with BamHI and SalI, and ligated into a
pGEX vector previously digested with the same en-
zymes so that the correct reading frame was main-
tained with thrombin cleavage site under the GST
gene. However, the r toxin contained two non-native
amino acids, Gly^Ser, added to the N-terminus as a
result of thrombin cleavage.
2.5. Site-directed mutagenesis
Site-directed mutagenesis was performed by the
unique restriction enzyme site elimination technique
using the Transformer mutagenesis kit (Clontech
Lab., Palo Alto, CA, USA) with synthetic appropri-
ate oligonucleotide primers as described previously
[14,15]. Plasmid pTB-1 was used as a template for
mutagenesis. All mutants obtained were identi¢ed by
sequencing with the Taq DyeDeoxy terminator cycle
sequencing kit (Applied Biosystems), as described
previously [14,15]. The variant toxin genes were li-
gated into a pGEX vector as described above. The
variant toxins constructed under the condition con-
tain two non-native amino acids, Gly^Ser, added to
the N-terminus.
2.6. Expression and puri¢cation of wild-type and
variant toxins
A 2-ml culture of L-broth containing 100 Wg/ml of
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ampicillin was inoculated with a single recombinant
colony of E. coli JM 109 bearing the desired con-
struct and incubated overnight at 37‡C with shaking.
One ml of this culture was then used to inoculate
larger cultures (100 ml of medium composed of tryp-
tone (Difco) 16 g, yeast extract (Difco) 10 g, NaCl 5 g
and 2% glucose/l) and the resulting culture was in-
cubated at 37‡C, with shaking at 300 rpm until
reaching an OD600 of 0.8^0.9. At this point, fusion
protein was induced by adding ¢ltered IPTG to
1 mM, and the culture was allowed to grow with
shaking at 300 rpm for 2 h. The culture was then
centrifuged at 4000Ug at 4‡C for 20 min. The super-
natant was decanted, and the cell pellet was sus-
pended in 10 ml of bu¡er A (140 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4,
pH 7.3) and the suspension was disrupted by soni-
cator on ice in short burst. The lysate was clari¢ed
by centrifugation at 40 000Ug at 4‡C for 30 min. The
supernatant of the lysate was applied directly to glu-
tathione^Sepharose column (Pharmacia). After ap-
plication of the lysate, the column was washed with
10 column volumes of bu¡er A. To the column was
added the thrombin solution (10 units) in bu¡er A to
enter into the bed of Sepharose and the bottom of
the column was capped, and the column allowed to
stand at room temperature for 16 h. Following in-
cubation, the column was eluted with bu¡er A to
elute protein. The protein fraction was chromato-
graphed on a Mono Q column (Pharmacia), previ-
ously equilibrated with 0.02 M Tris^HCl bu¡er (pH
8.0), and wild-type or variant toxins were separated
from thrombin.
2.7. Production of polyclonal mouse antisera
Anti-L-toxin antiserum was prepared by immuniz-
ing mice (about 20 g) with a toxoid obtained from n
toxin by treatment with 0.4% formalin at 37‡C for
2 days. Freund’s complete adjuvant was mixed with
the antigen, and intrasubcutaneous injections (con-
taining 10 Wg of protein) were given at 2-week inter-
vals. Blood was collected 10 days after immuniza-
tion.
2.8. SDS^PAGE and Western blot
The proteins were separated by sodium dodecyl
sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) in gels containing 12.5% polyacrylamide
and visualized by Coomassie brilliant blue. For
Western blots, proteins were transferred by electro-
plating onto polyvinylidene di£uoride membrane
(Immobilon P, Millipore). The membrane ¢rst was
incubated with polyclonal anti-n toxin (mouse) anti-
serum (diluted 1:1000) and then with anti-mouse
IgG-peroxidase conjugate (diluted 1:10 000) (Amer-
sham). Wild-type and variant toxins on the mem-
brane were visualized by the enhanced chemilumines-
cence Western blotting analysis system (Amersham)
[14,15].
2.9. Chemical modi¢cation
L-Toxin and variant toxins were modi¢ed by
NEM, sulfhydryl group reagent [9,10] or ethoxyfor-
mic anhydride (EFA), histidine residue modifying
agent [16] as described previously.
2.10. Biological activity
Male mice of the ddY strain, weighing 20^25 g,
were used. Toxicity was determined by i.v. injection
of serial dilutions (0.1 ml of the toxin solution) into
groups of four mice (20^25 g). Deaths occurring
within 24 h were recorded.
2.11. Others
The N-terminal amino acid sequence of the toxin
was determined as described previously [11] using a
protein sequencer (473A, Applied Biosystems). Cir-
cular dichroism (CD) spectra were recorded with a
spectropolarimeter (Jasco, J-500C, Tokyo, Japan) as
described previously [17]. Protein contents were as-
sayed by the method described by Lowry et al. [18].
3. Results
3.1. Puri¢cation and lethal activity of r toxin from
GST-L-toxin fusion protein
The supernatant £uid of the sonicated E. coli
transformant cells was analyzed by Western blotting
using antisera against GST and n toxin. A single
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band of about 62 kDa was detected by anti-n toxin
antiserum, suggesting that GST-L-toxin fusion pro-
tein was produced by the E. coli transformant cells.
After application of supernatant £uid of the soni-
cated cells to glutathione^Sepharose a⁄nity column,
the thrombin solution was applied to the column.
The column stood at room temperature for 16 h
and then r toxin was eluted with the bu¡er. To sep-
arate r toxin and thrombin, the toxin fraction was
loaded onto a Pharmacia fast-performance liquid
chromatography Mono-Q HR55 column preequiva-
lent with 20 mM Tris^HCl (pH 8.0) and the column
was eluted with a 25 ml of gradient from 0 to 1 M
NaCl in 20 mM Tris^HCl (pH 8.0). The toxin was
eluted as a sharp peak at a chloride concentration of
about 200 mM (data not shown). The purity of the
preparation was tested by SDS^PAGE. Fig. 1 shows
that a single band of about 35 kDa was observed by
Coomassie brilliant blue staining and the mobility of
the preparation was identical to that of n toxin. We
analyzed the N-terminal amino acid sequence of the
puri¢ed preparation using an automated protein se-
quencer. The amino acid sequence was G-S-N-D-I-
G-K-T-T-T (data not shown). Therefore, it is appar-
ent that the r toxin contains an additional Gly^Ser
linked to the N-terminus of n toxin, judging from
that obtained by nucleic acid sequencing of the
L-toxin gene [11]. The yield of the r toxin was about
1 mg/l of culture.
To determine the e¡ect of the additional two ami-
no acids linked to the N-terminus of r toxin on lethal
activity of L-toxin, the activity of r toxin and n toxin
was tested in mice. As shown in Table 1, a dose of
30 ng of n toxin or r toxin per mouse killed them
within 24 h, but when given 15 ng of these toxins, no
death occurred. The result shows that lethal activity
of r toxin was as active as that of n toxin, indicating
that the addition of the two amino acids causes no
e¡ect on the activity of L-toxin.
3.2. Production and puri¢cation of variant L-toxins
To clarify the role of the Cys-265 residue and ami-
no acid residues (Glu-262, Tyr-266, Leu-268, Trp-270
and Trp-275) near the cysteine residue in the toxin,
site-directed mutagenesis was employed to convert
these amino acid codons to one for alanine, glycine,
histidine, phenylalanine, serine or tyrosine. On the
constructed plasmids, modi¢cations of the Cys codon
and these amino acid codons of the L-toxin gene
were identi¢ed by nucleic acid sequencing (data not
shown). Putative variant L-toxin genes were ex-
pressed as a GST-variant L-toxin fusion proteins in
E. coli. According to the puri¢cation procedure of r
toxin, GST-L-toxin fusion proteins were puri¢ed
from the sonicate of these E. coli transformant cells
and variant L-toxins were isolated by treatment of
Fig. 1. SDS^PAGE and Western blot of native L-toxin, re-
combinant L-toxin and variant L-toxins. (A) The puri¢ed prepa-
ration (5 Wg of protein) was electrophoresed by SDS^PAGE
(12.5% polyacrylamide gel) followed by staining 1% (w/v) Coo-
massie brilliant blue. (B) The puri¢ed preparation (0.5 Wg of
protein) was electrophoresed and subsequently electroblotted to
PVDF membrane (Millipore). The immunoblot analysis were
performed with anti-n toxin antitoxin as described in the text.
Lane assignments: M, molecular mass marker: lane 1, n toxin
puri¢ed from culture of C. perfringens : lane 2, r toxin: lane 3,
C265A: lane 4, C265S: lane 5, C265H: lane 6, C265Y.
Table 1
Lethal activity of native, recombinant and variant L-toxins
Native, recombinant or variant L-toxin was injected into mice
intravenously. Deaths occurring within 24 h were recorded.
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these fusion proteins with thrombin. Puri¢ed C265A,
C265S, C265H and C265Y showed a single band of
35 kDa by Coomassie brilliant blue staining and im-
munoblotting on SDS^PAGE (Fig. 1). In addition,
the mobility of E262A, Y266A, L268G, W270F and
W275A was isolated as a single band with 35 kDa
and the mobility of these variant toxins was identical
to that of r toxin on SDS^PAGE (data not shown).
3.3. Lethal activity of variant C265A, C265S, C265H
and C265Y
Lethal activity of these variant toxins at position
265 was determined in order to test if the cysteine
residue is required for the activity (Table 1). Replace-
ment of Cys-265 with alanine or serine resulted in
little loss of the activity. However, the substitution
of tyrosine or histidine for Cys-265 signi¢cantly di-
minished lethal activity by approximately 16-fold of
the activity of r toxin. We have reported that treat-
ment of L-toxin with sulfhydryl group reagents such
as NEM causes drastic loss of lethal and dermone-
crotic activities [9,10]. The e¡ect of 5 mM NEM on
lethal activity of r toxin and C265A was investigated
(Table 2). Treatment of r toxin with the reagent re-
duced lethal activity by 32-fold of the activity of the
untreated toxin, but the treatment of C265A led to
little loss of the activity. In addition, to explore the
e¡ect of the chemical modi¢cation of the amino acid
at position 265 on the activity of the toxin, r toxin
and C265H were treated with 0.05 mM EFA, which
is known to modify histidyl residue [16]. C265H was
more sensitive to EFA than r toxin, as shown in
Table 2.
To test whether replacement of the cysteine residue
in r toxin causes conformational changes, r toxin and
variant L-toxins (C265A, C265S, C265H and C265Y)
were analyzed by CD study. The r toxin and these
variant toxins showed a negative ellipticity band at
approximately 215 nm and CD spectra of toxin were
not di¡erent from that of these variant toxins (data
not shown).
3.4. Lethal activity of variant E262A, Y266A, L268G,
W270G and W275A
Hydropathy analysis of L-toxin shows that the
Fig. 2. (A) Predicted hydropathy of L-toxin. The hydropathic
potentials of L-toxin (247^286 residues) were predicted by the
method of Hopp and Woods [31]. Positive values within the
plot indicate hydrophilicity and negative values indicate hydro-
phobicity. (B) Alignment of deduced amino acid sequences of
C. perfringens L-toxin and S. aureus K-toxin (Hla) and fast
component of leucocidine (Luk F). (*) Identical residues with
all toxins; ( :) identical residues with L-toxin and Hla; (.) identi-
cal residues with L-toxin and Luk F.
Table 2
E¡ect of N-ethylmaleimide and ethoxyformic anhydride on le-
thal activity of recombinant L-toxin, C265A and C265H
The NEM or EFA-treated r L-toxin or variant toxin (0.1 ml)
was injected i.v. into separate groups of four mice. Deaths oc-
curring within 24 h were recorded.
aRecombinant L-toxin or C265A was incubated in 100 Wl of
0.01 M phosphate bu¡er (pH 7.0) containing N-ethylmaleimide
(NEM) for 30 min at 37‡C.
bRecombinant L-toxin or C265H was incubated in 100 Wl of
0.01 M phosphate bu¡er (pH 7.0) containing ethoxyformic an-
hydride (EFA) for 30 min at 37‡C.
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Cys-265 residue exists between a hydrophilic region
and a hydrophobic region as shown in Fig. 2. Re-
placement of Glu-262 in the hydrophilic region with
alanine resulted in no loss of the activity. Tyr-266,
Leu-268, Trp-270 and Trp-275 in the hydrophobic
region were replaced with glycine, phenylalanine or
alanine. Y266A, L268G and W275A showed no le-
thal activity under our experimental conditions, but
W270F showed no loss of lethal activity. The result
suggested that Tyr-266, Leu-268 and Trp-275 are es-
sential to the activity.
To investigate the role of Tyr-266, Leu-268 and
Trp-275 on lethal activity, the e¡ect of these variant
toxins on lethal activity of n toxin was determined
(Table 3). Sixty ng of n toxin was mixed with various
concentrations of Y266A, L268G or W275A and the
mixtures were intravenously injected into mice.
W275A over the concentrations 300 ng of completely
inhibited lethal activity of n toxin, but 600 ng of
Y266A and L268G caused no e¡ect on the activity.
4. Discussion
Puri¢cation of L-toxin from culture supernatant
£uid of C. perfringens type C has proved di⁄cult
for various reasons as follows: (1) the toxin is ther-
molabile and sensitive to proteinases, (2) the toxin is
inactivated by sulfhydryl group or oxidizing agents,
(3) the toxin is easy of being polymeric form, which
has no activity, in the solution, and this polymeric
form is di⁄cult to be dissociated to the monomeric
form or the active form [2,3]. The L-toxin gene from
C. perfringens type B has been cloned and sequenced
[11]. However, expression of the cloned toxin gene in
E. coli caused in production of the polymeric form,
which was not biologically active [11]. Steinthorsdot-
tir et al. [12] reported that treatment of the GST-L-
toxin fusion protein with Factor Xa, which hydro-
lyzes the bond between arginine and glycine, resulted
no release of the active form of L-toxin from the
fusion protein which was bound with I-E-G-R-G-I-
P. In the present work, we established the isolation
procedure of the active r toxin by thrombin cleavage
of the GST-L-toxin fusion protein that was linked
with L-V-P-R-G-S. The r toxin contained an addi-
tional Gly^Ser linked to the N-terminus of n toxin as
expected, and the activity of the r toxin was as active
as that of the n toxin. Accordingly, the role of the
Cys-265 residue and amino acid residues near the
cysteine residue was analyzed by site-directed muta-
genesis using the gene of the r toxin.
The data presented here provide clear evidence
that the single cysteine residue in L-toxin sensitive
to sulfhydryl group reagents and oxidizing agents is
not an essential residue for the lethal activity. Re-
placing the single cysteine residue in L-toxin with
alanine or serine had no signi¢cant e¡ect on the le-
thal activity. Steinthorsdottir et al. [19] reported that
replacement of Cys-265 with serine resulted in no
e¡ect on the lethal activity. Such a ¢nding is not
only con¢ned to L-toxin. Site-directed mutagenesis
of Streptococcus pneumoniae pneumolysin, Strepto-
coccus pyogenes streptolysin O and Listeria monocy-
togenes listeriolysin, which are inactivated by sulf-
hydryl group reagents and oxidizing agents, has
revealed that the cysteine residue is not essential
for the cytolytic activity of these thiol-activated tox-
ins [20^23]. The inhibitory e¡ect of sulfhydryl group
reagents and oxidizing agents on L-toxin may be
similar to that of these agents on thiol-activated tox-
ins [20^23].
Replacement of the cysteine residue with histidine
or tyrosine resulted in signi¢cant reduction in lethal
activity of L-toxin. Generally it is unlikely that con-
formational changes in a protein are induced by a
single amino acid replacement. In addition, CD spec-
tra study indicated no di¡erence between r toxin and
these variant toxins, suggesting that the replacement
of Cys-265 causes little conformational change. It
therefore appears that the substitution of amino
Table 3
E¡ect of W275A, Y266A and L268G on the lethal activity of
L-toxin









L-Toxin and Y266A, L268G or W275A were simultaneously in-
jected into mice. Deaths occurring within 24 h were recorded.
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acids, which have a larger size of side chain, for the
cysteine causes reduction in the activity. Moreover,
chemical modi¢cation of r toxin and C265H by
NEM and EFA, respectively, led to a signi¢cant re-
duction in lethal activity, showing that introduction
of functional groups into amino acid at position 265
diminishes the activity. It therefore appears that
these inhibitory e¡ects on lethal activity of L-toxin
seems to re£ect induction of steric hindrance or sec-
ondary structure changes at position 265, or both.
The thiol-activated toxins are known to have the
conserved motif containing the cysteine residue
(ECTGLAWEWWR) [24]. From the deduced amino
acid sequence of L-toxin, the cysteine residue in
L-toxin also is found to be included within the
same CXXLXW sequence as thiol-activated toxins,
although the sequence similarity between L-toxin and
the thiol-activated toxins is very weak. It therefore is
likely that the site adjacent to the cysteine residue in
L-toxin is similar to that in thiol-activated toxins.
Mitchell et al. [21] and Sekino-Suzuki et al. [24] re-
ported that other substitutions within the conserved
motif containing the cysteine residue in thiol-acti-
vated toxins have been shown to reduce hemolytic
activity, suggesting that the site adjacent to the cys-
teine residue is located at a functionally important
site in the toxin molecule. Replacement of Tyr-266,
Leu-268 and Trp-275 in L-toxin resulted in complete
loss of the activity, suggesting that these residues are
important for lethal activity of L-toxin. Furthermore,
the site adjacent to the cysteine residue seems to play
an essential role for the activity. The thiol-activated
toxins are known to be a pore-forming toxin, sug-
gesting that the region surrounding the cysteine res-
idue may be related to e⁄cient oligomerization.
Hunter et al. [11] reported 28% of similarity to
L-toxin to S. aureus K-toxin and leukocidin S. The
ability of L-toxin to form polymeric form and the
amino acid homology to these pore-forming toxins
suggest pore formation as a potential mechanism of
action for the L-toxin. Song et al. [25] reported that
the membrane spanning region of S. aureus K-toxin
participates in crucial protomer^protomer interac-
tion as well as being important in conformational
rearrangements involved in oligomer formation in
the membrane bound form (position at 103 to 109,
and 148 to 151). Valeva et al. [26] reported that the
central molecular region of K-toxin is divided into
two functional domains: the region at position 118
to 124 participates in assembly of the pre-pore, and
that the region at position 126 to 140 inserts into the
lipid bilayer and become part of the pore wall. These
regions of the K-toxin correspond to those at posi-
tions 118 to 167 in L-toxin. On the other hand,
Jursch et al. [27] reported that replacement of His-
259 in the K-toxin with serine and isoleucine resulted
in reduction in binding to rabbit erythrocytes, sug-
gesting that the C-terminus of the K-toxin is involved
in binding to erythrocytes. Bayley and his group [28^
30] have reported that the C-terminus of the K-toxin
is important for oligomerization. Walker and Byley
[30] reported that replacement of Arg-200 in the K-
toxin caused loss of hemolytic activity. Steinthors-
dottir et al. [19] reported that a corresponding L-tox-
in mutant toxin (R212E) showed low lethal activity.
It therefore is suggested that L-toxin forms a mem-
brane-active oligomer. As shown in Fig. 2, the pri-
mary amino acid sequence surrounding Cys-265 in
L-toxin (positions 255 to 276) is homologous to
that at positions 245 to 267 in the C-terminus of K-
toxin (a conserved 11-amino acid sequence), showing
that the region adjacent to Cys-265 corresponds to
the C-terminus of K-toxin and that Cys-265 in L-tox-
in corresponds to Asp-255 in the K-toxin. Walker
and Bayley [30] reported that treatment of D254C
and D255C (variant toxins of the K-toxin) with the
sulfhydryl reagent, 4P-acetamido-4-((iodoacetyl)ami-
no)stilbene-2,2P-disulfonate, resulted in signi¢cant re-
duction or complete loss of binding, oligomer forma-
tion and hemolytic activity, suggesting that
C-terminus of the K-toxin is implicated in binding
to cells and that the region surrounding Cys-265 in
L-toxin may be required for binding to the receptor
of L-toxin or formation of oligomerization.
On the basis of the hydropathy of L-toxin, the
cysteine residue at position 265 is on the border be-
tween the hydrophilic region at position 256 to 264
and the hydrophobic region at position 265 to 280
(Fig. 2). Lethal activity of n toxin was inhibited by
simultaneous injection of n toxin and W275A, but
not by that of Y226A and L268G. W275A seems
to inhibit binding of the toxin to receptor or oligom-
er formation, but Y226A and L268G does not. Trp-
275 in L-toxin may be important for formation of
e⁄cient oligomer and Tyr-266 and Leu-268 may be
required for binding to receptor or oligomer forma-
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tion, suggesting that the region adjacent to the cys-
teine residue contributes to a functionally important
structure and that the essential site for the activity of
L-toxin is present in the hydrophobic region. The
hydrophilic region is generally thought to be exposed
toward the outside of the molecule and the hydro-
phobic region to be buried in the molecule. It is
possible that the cysteine residue at position 265 is
located at the entrance of the hydrophobic region or
the cavity. It therefore appears that the introduction
of functional groups by amino acid modifying agents
such as NEM to the cysteine residue and replacement
of the residue with amino acid with a large size of
side chain such as tyrosine and histidine results in
steric hindrance to pore formation of L-toxin or the
access of the toxin to receptor. A cytotoxicity model
with cultured cells should be more suitable to address
this question. This is now the subject of investigation
in our laboratory.
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